Entity Name: | ZYMEWORKS BIOPHARMACEUTICALS INC. |
Jurisdiction: | FLORIDA |
Filing Type: | Foreign Profit |
Status: |
Active
The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness. |
Date Filed: | 23 Feb 2021 (4 years ago) |
Document Number: | F21000001078 |
FEI/EIN Number |
47-2569713
Federal Employer Identification (FEI) Number assigned by the IRS. |
Address: | 777 108th Avenue NE, Suite 1700, Bellevue, WA, 98004, US |
Mail Address: | 777 108th Avenue NE, Suite 1700, Bellevue, WA, 98004, US |
Place of Formation: | WASHINGTON |
Name | Role | Address |
---|---|---|
Galbraith Kenneth | Chief Executive Officer | 777 108th Avenue NE, Bellevue, WA, 98004 |
Astle Chris | Treasurer | 777 108th Avenue NE, Bellevue, WA, 98004 |
Dex Daniel | Secretary | 777 108th Avenue NE, Bellevue, WA, 98004 |
Moore Paul | Chie | 777 108th Avenue NE, Bellevue, WA, 98004 |
Galbraith Kenneth | Chairman | 777 108th Avenue NE, Bellevue, WA, 98004 |
Astle Chris | Director | 777 108th Avenue NE, Bellevue, WA, 98004 |
CT CORPORATION SYSTEM | Agent | 1200 SOUTH PINE ISLAND ROAD, PLANATION, FL, 33324 |
Event Type | Filed Date | Value | Description |
---|---|---|---|
CHANGE OF PRINCIPAL ADDRESS | 2024-03-01 | 777 108th Avenue NE, Suite 1700, Bellevue, WA 98004 | - |
CHANGE OF MAILING ADDRESS | 2024-03-01 | 777 108th Avenue NE, Suite 1700, Bellevue, WA 98004 | - |
Name | Date |
---|---|
ANNUAL REPORT | 2024-03-01 |
ANNUAL REPORT | 2023-05-15 |
ANNUAL REPORT | 2022-06-15 |
Foreign Profit | 2021-02-23 |
Date of last update: 03 Mar 2025
Sources: Florida Department of State